Researchers have taken a big step forward in the quest to regenerate the pancreatic beta-cells damaged by type 1 diabetes. Using FDA-approved drugs usually given to patients with rare cancers, they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback